Pilot studies demonstrate the potential benefits of antiinflammatory therapy in human lymphedema

• DOI: 10.1172/jci.insight.123775
• Publication Date: 2018-10-17T15:01:49Z
• Authors: Stanley G. Rockson; Wen Tian; Xinguo Jiang; Tatiana Kuznetsova; Francois Haddad; Jamie Zampell; Babak Mehrara; Joshua P. Sampson; Leslie Roche; Jinah Kim; Mark R. Nicolls
• Keywords: Ketoprofen

BACKGROUND. Lymphedema is a common condition affecting millions around the world that still lacks approved medical therapy. Because ketoprofen, an NSAID, has been therapeutic in experimental lymphedema, we evaluated its efficacy humans.